The centralized procurement of in-vitro diagnostic reagents is an important part of the strategic purchase and centralized medical procurement management in the field of medical reform in China. At present, various procurement work modes have both advantages and disadvantages and need to be improved. This paper introduces, compares and analyzes four current main procurement work modes, including hospital-level independent non-centralized procurement, prefectural-level centralized bidding procurement, provincial-level centralized online procurement, and provincial-level centralized procurement with volume, and puts forward policy suggestions.
Key words
in-vitro diagnostic reagents /
centralized procurement /
mode /
suggestion
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 国务院办公厅.国家食品药品监督管理总局令(第5号)体外诊断试剂注册管理办法[EB/OL].(2014-07-30)[2022-05-13]. http://www.gov.cn/gongbao/content/2014/content_2758501.htm.
[2] IVD行业深度研究系列报告(一)[R].IVD行业深度研究系列报告(一)[R].上海:中银证券,2021.
[3] 中国医疗器械上市公司发展白皮书——体外诊断篇[R].中国医疗器械上市公司发展白皮书——体外诊断篇[R].上海:华夏基石,2019.
[4] 张煜唯. 集中采购下体外诊断试剂价格畸高与竞争政策[D].大连:东北财经大学,2019.
[5] 花陈祥. 体外诊断试剂价格决策研究——以RDSH公司为例[D].上海:华东理工大学,2016.
[6] 曹群,陈富强,方沅湘等.大型医院临床应用体外诊断试剂采购管理策略研究[J].中国医院. 2018(03):66-68.
[7] 陈燕,佘艳.体外诊断试剂公开招标实践与分析[J].中国招标,2019(03):44-46.